KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Current Assets (2016 - 2025)

Exact Sciences has reported Current Assets over the past 16 years, most recently at $1.6 billion for Q4 2025.

  • Quarterly Current Assets fell 0.99% to $1.6 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.6 billion through Dec 2025, down 0.99% year-over-year, with the annual reading at $1.6 billion for FY2025, 0.99% down from the prior year.
  • Current Assets was $1.6 billion for Q4 2025 at Exact Sciences, down from $1.6 billion in the prior quarter.
  • Over five years, Current Assets peaked at $1.8 billion in Q1 2021 and troughed at $982.3 million in Q4 2022.
  • The 5-year median for Current Assets is $1.4 billion (2021), against an average of $1.4 billion.
  • Year-over-year, Current Assets plummeted 35.13% in 2021 and then skyrocketed 33.53% in 2024.
  • A 5-year view of Current Assets shows it stood at $1.4 billion in 2021, then plummeted by 31.13% to $982.3 million in 2022, then grew by 21.59% to $1.2 billion in 2023, then surged by 31.57% to $1.6 billion in 2024, then decreased by 0.99% to $1.6 billion in 2025.
  • Per Business Quant, the three most recent readings for EXAS's Current Assets are $1.6 billion (Q4 2025), $1.6 billion (Q3 2025), and $1.5 billion (Q2 2025).